Pharmaceutical Industry News

Rhythm Pharmaceuticals director Jennifer Good sells over $1.6m in stock, a move that has sparked curiosity and analysis within the pharmaceutical industry. This significant transaction raises questions about the company’s current financial standing and future prospects, especially in the context of its focus on developing treatments for rare diseases. Jennifer …

Serina Therapeutics director buys $88.2k in company stock sets the stage for this enthralling narrative, offering readers a glimpse into a story that is rich in detail and brimming with originality from the outset. This significant investment by a high-ranking executive signals a strong vote of confidence in the company’s …